Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy
Type 2 diabetes mellitus (T2DM) is a global health concern, with diabetic neuropathy (DN) being a prevalent complication. Current DN treatments focus on blood glucose control and pain management, which show limited efficacy. This study explored the effects of autologous dendritic cell (DC) administr...
Saved in:
| Main Authors: | Erwin Setiawan, Chrismis Novalinda Ginting, Jonny Jonny, Bhimo Aji Hernowo, Terawan Agus Putranto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/46/12/861 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffusion Tensor Imaging Magnetic Resonance Imaging Assessment in a Clinical Trial of Autologous Dendritic Cell Transfer for Diabetic Kidney Disease: A Molecular Approach
by: Ernaldi Kapusin, et al.
Published: (2025-05-01) -
Clinical Trial: Effects of Autologous Dendritic Cell Administration on Renal Hemodynamics and Inflammatory Biomarkers in Diabetic Kidney Disease
by: Endang Drajat, et al.
Published: (2025-04-01) -
Oxaliplatin-related neuropathy in Indian patients – no difference between generic and original molecules
by: Bhawna Sirohi, et al.
Published: (2016-01-01) -
Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation
by: Orlando G. Povoas Barsottini, et al.
Published: (2004-09-01) -
Clinical profile and visual outcomes in ethambutol-induced toxic optic neuropathy
by: Jenil Sheth, et al.
Published: (2025-06-01)